Los Angeles Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
+125,408
| New | +$1.03M | ﹤0.01% | 630 |
|
|
2023
Q2 | – | Sell |
-19,479
| Closed | -$368K | – | 1269 |
|
|
2023
Q1 | $368K | Sell |
19,479
-14,781
| -43% | -$280K | ﹤0.01% | 951 |
|
|
2022
Q4 | $777K | Sell |
34,260
-2,678
| -7% | -$60.7K | ﹤0.01% | 775 |
|
|
2022
Q3 | $976K | Sell |
36,938
-23,982
| -39% | -$634K | 0.01% | 706 |
|
|
2022
Q2 | $1.51M | Buy |
60,920
+32,680
| +116% | +$807K | 0.01% | 602 |
|
|
2022
Q1 | $937K | Buy |
+28,240
| New | +$937K | ﹤0.01% | 788 |
|
|
2019
Q4 | – | Sell |
-21,787
| Closed | -$776K | – | 1335 |
|
|
2019
Q3 | $776K | Sell |
21,787
-5
| -0% | -$178 | ﹤0.01% | 873 |
|
|
2019
Q2 | $1.12M | Hold |
21,792
| – | – | 0.01% | 810 |
|
|
2019
Q1 | $1.25M | Buy |
21,792
+10,600
| +95% | +$608K | 0.01% | 783 |
|
|
2018
Q4 | $470K | Buy |
11,192
+225
| +2% | +$9.45K | ﹤0.01% | 980 |
|
|
2018
Q3 | $828K | Buy |
10,967
+5,120
| +88% | +$387K | ﹤0.01% | 948 |
|
|
2018
Q2 | $420K | Buy |
+5,847
| New | +$420K | ﹤0.01% | 1187 |
|